for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

RaQualia Pharma Inc

4579.T

Latest Trade

1,298.00JPY

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

970.00

 - 

2,210.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

RaQualia Pharma says status of formation of JV with ZTE Coming Biotech

June 29 (Reuters) - RaQualia Pharma Inc <4579.T>:Says it will set up a Jiangsu-based JV with Shanghai-based firm ZTE Coming Biotech Co., Ltd within 2018.Says the JV will be engaged in R&D of pharmaceutical.Previous news was disclosed on May 31.

RaQualia Pharma updates establishment of pharmaceutical JV with ZTE Coming Biotech

May 31 (Reuters) - RaQualia Pharma Inc <4579.T>:Says it will set up a JV, which will be engaged in research and development of pharmaceutical, with Shanghai-based firm ZTE Coming Biotech Co., Ltd, in September .The JV will be capitalized at 10 million yuan .

RaQualia Pharma says license agreement for novel P2X7 receptor antagonist

March 26(Reuters) - RaQualia Pharma Inc <4579.T>:Says it and Asahi Kasei Pharma Corp have entered into a license agreement for a novel P2X7 receptor antagonist discovered through a research collaboration between the two companies.

RaQualia Pharma plans pharmaceutical JV with ZTE Coming Biotech

Jan 29(Reuters) - RaQualia Pharma Inc <4579.T>:Says it plans to set up a JV, which will be engaged in research and development of pharmaceutical, with Shanghai-based firm ZTE Coming Biotech Co., Ltd, in May.Says the company and ZTE Coming Biotech will hold a 35 percent stake and a 65 percent stake in the JV respectively.

RaQualia Pharma to sign license agreements with CJ HealthCare

Dec 28 (Reuters) - RaQualia Pharma Inc <4579.T>:Says it plans to sign license agreements with CJ HealthCare regarding RQ-00000004(tegoprazan) and crystal of RQ-00000004(tegoprazan) .

RaQualia Pharma says termination of 5-HT4 partial agonist related license agreement

Dec 28 (Reuters) - RaQualia Pharma Inc <4579.T>:Says co and South Korea-based firm CJ HealthCare terminate 5-HT4 partial agonist (RQ-00000010) related license agreement .

RaQualia Pharma signs license agreement with Maruho on selective Na sodium channel blocker

Dec 25 (Reuters) - RaQualia Pharma Inc <4579.T> ::Says it and Maruho Co Ltd planed to enter into license agreement, regarding selective Na sodium channel blocker, on Dec. 25.

RaQualia Pharma ends license agreement related to EP4 antagonist

Nov 29 (Reuters) - RaQualia Pharma Inc <4579.T>:Says it ends license agreement with Maruishi Pharmaceutical Co Ltd regarding EP4 antagonist.

RaQualia Pharma announces exercise of options

Oct 16(Reuters) - RaQualia Pharma Inc <4579.T>:Says 1,000 units of its 14th series options were exercised to 1 million shares of its common stock, by Daiwa Securities Co. Ltd., during period from Oct. 10 to Oct. 16.

RaQualia Pharma says exercise of options

Oct 12 (Reuters) - RaQualia Pharma Inc <4579.T>:Says 180 units of its 14th series options were exercised to 180,000 shares of its common stock on Oct. 12.Says the shares were exercised at the price of 976.5 yen per share.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up